Long-term conditions in West Bengal, followed as one person, not five lists
West Bengal now has more raised blood sugar and blood pressure than India as a whole, and the gap opened in the last three years. Anubhav Life Care, a neighbourhood lab in Barasat, holds four years of results for 1,15,829 people. This page sets the state against the country, then shows what those results say: how common each condition is among the people tested, how often they come together, which follow-up checks never happen, and what changes in the same person over time.
Lab figures: real, from the lab's AKTIV records, Oct 2022 to Oct 2026, 1,74,520 visits linked into 1,15,829 people, 4,35,472 numeric results, 81,776 ultrasound and 8,883 echo reports; published as counts only · West Bengal and India figures: published surveys, cited.
62%
of adults tested have at least one chronic condition
of 61,474 tested in at least one of nine areas
20.1%
of adults tested for sugar have diabetes
women 17.4%, men 24.0%; n 24,915
36.6%
of people with diabetes ever had an HbA1c
7,843 people; 7.2% ever had a urine ACR
59%
of people aged 60-74 have two or more conditions
among those tested in three or more areas
West Bengal against India
Noncommunicable diseases cause 63% of deaths in India (WHO). Every West Bengal and India figure is published and linked to its source; the last column of the condition table is the lab's own.
NFHS-6 2023-24 vs NFHS-5 2019-21adults 15+ unless stated
Same survey, same method: West Bengal and India
% of adults, NFHS-6 2023-24; the dark tick marks NFHS-5 2019-21
Women: blood sugar over 140 mg/dL or on medicine
West Bengal22.7% +5.2 since NFHS-5Anubhav 17.4%
India17.8% +4.3 since NFHS-5
Men: blood sugar over 140 mg/dL or on medicine
West Bengal26.8% +5.5 since NFHS-5Anubhav 24.0%
India20.9% +5.3 since NFHS-5
Women: blood sugar over 160 mg/dL
West Bengal12.1% +4.4 since NFHS-5
India9.1% +2.8 since NFHS-5
Men: blood sugar over 160 mg/dL
West Bengal14.3% +4.8 since NFHS-5
India10.9% +3.8 since NFHS-5
Women: blood pressure 140/90+ or on medicine
West Bengal24.3% +3.8 since NFHS-5
India19.4% −1.9 since NFHS-5
Men: blood pressure 140/90+ or on medicine
West Bengal24.9% +4.8 since NFHS-5
India22.1% −1.9 since NFHS-5
Women 15-49: overweight or obese (BMI 25+)
West Bengal34.6% +11.9 since NFHS-5
India30.7% +6.7 since NFHS-5
Men 15-49: overweight or obese (BMI 25+)
West Bengal24.5% +8.3 since NFHS-5
India27.3% +4.4 since NFHS-5
Men: use any tobacco
West Bengal46.2% −1.9 since NFHS-5
India36.3% −1.7 since NFHS-5
West Bengal
India
Anubhav Life Care, adults tested
West Bengal is above India on every blood sugar and blood pressure measure, for women and for men. Raised blood pressure rose in West Bengal (women 20.5% to 24.3%, men 20.1% to 24.9%) while it fell nationally. Blood sugar over 160 mg/dL, the level that usually means untreated or uncontrolled diabetes, rose by about half in five years. The sun marks Anubhav's adults with confirmed diabetes: women 17.4%, men 24.0%, a little under the state's survey figure, which also counts any single random reading over 140. The lab has no blood pressure, weight or tobacco data, so those rows have no mark. Source: NFHS-6 (2023-24) fact sheets, IIPS / MoHFW 2026.
Condition by condition
best published estimate for each; studies differ in method, age and year, so read across a row with care
61.6%women 69.9% / men 45.4% · WHO haemoglobin cut-offs, all adults; n 21,521
The lab column is not a prevalence. People come to a lab because a doctor suspected something, so it runs above a household survey wherever testing is selective: fatty liver and kidney disease most of all, because scans and creatinine are ordered for people with symptoms or diabetes. Where testing is routine the lab sits close to the survey: diabetes among women 17.4% against NFHS-6's 22.7% for West Bengal, anaemia among women 69.9% against NFHS-5's 71.4%, hypothyroidism 23.9% against Kolkata's 21.7%. All three sit above India.
What the lab found
Every condition the lab's results can define, among adults who had the test that defines it. Definitions follow ADA, KDIGO, NCEP, ATA and WHO; ultrasound and echo findings are read from the report text by rule-based extractors on the clinic PC, which send back flags, never text. The standardised column reweights each rate to the age and sex mix of all 1,02,882 adults seen, so conditions tested mostly in older people can be compared with the rest.
Oct 2022 to Oct 20261,02,882 adults63.8% womenmedian age 40
Read each row as “of the adults who had this test”. Fatty liver on 52.3% of scans is a referral rate, not a state rate; the 2010 rural West Bengal survey found 8.7%. eGFR under 60 at any test (13%) overstates kidney disease because most people had one creatinine; only 1.7% were confirmed 90 days apart. Breathing tests (548) and PSA (738) are too few to quote.
Per 1,000 adults tested, by year
same definitions each year; 2022 covers November and December only
Year
Adults seen
Diabetes
Dyslipidaemia
CKD (eGFR<60)
Fatty liver
Hypothyroid
Anaemia
Structural heart dis.
2022
2,180
300
679
109
550
237
653
122
2023
20,507
323
714
131
536
273
628
132
2024
30,051
332
697
125
571
241
649
112
2025
36,375
344
667
138
519
216
599
109
2026
32,126
340
655
134
531
227
612
125
Diabetes per 1,000 adults tested rose from 323 in 2023 to 344 in 2025, in the same direction as NFHS-6. Who gets tested also changes from year to year, so treat this as agreement, not a trend estimate.
The same people, with several conditions
Visits are linked into one person by phone number, name, sex and age, so each person is counted once however often they came. Nine areas are counted: diabetes, dyslipidaemia, kidney disease, fatty liver, hypothyroidism, anaemia, raised uric acid, structural heart disease and raised liver enzymes.
20,609 adults tested in 3+ areasCKM: 52,671 adults staged
Conditions per person
adults tested in three or more of the nine areas, n = 20,609
None15%
One36.4%
Two28.4%
Three14.2%
Four or more6%
Nearly half the people tested broadly (48.6%) have two or more conditions. Restricting to people tested in three areas leans toward the sicker; among everyone tested in at least one area the figure is 18.6%.
Two or more conditions, by age
same people
18-2926.1%
30-4446%
45-5955.8%
60-7459%
75+65.1%
A quarter of people under 30 tested this broadly already have two conditions. From 45 on it is more than half.
Commonest combinations
people with exactly this set of conditions, tested in 3+ areas
Dyslipidaemia + Anaemia647
Hypothyroid + Anaemia563
Anaemia + Transaminitis558
Diabetes + Anaemia546
Fatty liver + Anaemia542
Diabetes + Dyslipidaemia483
CKD/albuminuria + Anaemia304
Dyslipidaemia + Transaminitis252
Dyslipidaemia + Fatty liver251
Fatty liver + Transaminitis243
What one condition says about another
adults tested for both; odds ratio adjusted for age and sex
If a person has
they also have
vs without
aOR
CKD (eGFR<60)
82.7% Anaemia
57.1%
2.8 (2.4–3.3)
Diabetes
77.8% Fatty liver
54.4%
2.3 (2.0–2.6)
Hyperuricaemia
20.9% CKD (eGFR<60)
9.3%
2.9 (2.3–3.7)
CKD (eGFR<60)
26.1% Structural heart dis.
8.5%
2.3 (1.6–3.3)
Diabetes
23.9% Proteinuria (dipstick)
8.7%
2.3 (1.9–2.9)
Diabetes
17.2% CKD (eGFR<60)
8.1%
1.8 (1.6–2.0)
Fatty liver
23.9% LVH
15.5%
1.5 (1.2–1.9)
High TG
60.9% Low HDL
37.6%
2.6 (2.4–2.9)
Kidney disease is the hub: it links to anaemia, the heart, uric acid and diabetes.
Cardiovascular-kidney-metabolic stage
adapted from AHA 2023 staging to what lab results can show; adults with a metabolic or kidney test, n = 52,671
Stage 0: no risk factors found43.2%
Stage 1: prediabetes or fatty liver32.6%
Stage 2: diabetes, triglycerides 135+ or kidney disease20.5%
Stage 3: advanced kidney disease or early heart change on echo2.9%
Stage 4: heart disease on echo or ECG0.7%
Stage 2 or above: 4.8% at 18-29, 32.7% at 45-59, 44.3% at 75 and over. Blood pressure and weight are not in lab records, so stages 1 and 2 are undercounted.
Checks that never happen
Guidelines ask for an HbA1c, a kidney check (creatinine and urine ACR) and a lipid profile at least once a year in diabetes, and a urine ACR in anyone with low eGFR. These are the shares who ever had each test at this lab in four years.
diabetes n = 7,843eGFR < 60 n = 1,975fatty liver n = 15,434
People with diabetes: ever tested
one diabetic-range result or more, n = 7,843
Creatinine47.8%
HbA1c36.6%
Lipid profile31.7%
Liver ultrasound19%
Echocardiogram9.2%
Urine ACR7.2%
Where the missing tests were done they found a lot: eGFR under 60 in 17.2%, albuminuria in 53.2% and fatty liver in 77.8%. Fewer than one in thirteen people with diabetes ever had the urine test that catches kidney damage early.
Latest HbA1c in people with diabetes
among those who had one
Under 7%37%
7 to 7.9%26.1%
8 to 8.9%14.8%
9 to 9.9%8.1%
10% or more14%
36.9% are at 8% or above, and 49.6% of those who started there were still there at their latest test.
Kidney disease
eGFR under 60 at any test, n = 1,975
Ever had a urine ACR13.5%
Anaemic, with eGFR under 6082.7%
Anaemic, with eGFR 60 or more57.1%
Stages: G1 25, G2 81, G3a 860, G3b 483, G4 308, G5 218. 526 people reached G4 or G5, the range where a nephrologist should already be involved.
Fatty liver
fatty liver on ultrasound, n = 15,434
Ever had liver enzymes (LFT)16.1%
Raised enzymes, where tested42.5%
FIB-4 not low, where computable37.9%
Grades: 11,978 grade I, 2,422 grade II, 87 grade III. FIB-4 is the blood score that decides who needs a fibrosis scan; it needs ALT, AST and platelets, which most scanned people never had.
What changes in the same person
27,448 adults came more than once and 9,371 were followed for a year or more. Their first and latest results show how fast conditions start and worsen when nobody is following them up.
25.7%
of people with prediabetic fasting sugar reached the diabetic range
19 per 100 person-years; n 1,000; 24% returned to normal
-2.3
mL/min per year, median eGFR change
n 1,277; 35.6% lost 5 or more a year
26.8%
of normal livers were fatty at the next scan
n 775, scans 6 months or more apart
6.0
new eGFR under 60 per 100 person-years with diabetes
vs 3.7 without; 47 and 26 events
New conditions during follow-up
negative in the first 180 days, retested later, followed a year or more
Diabetes25.7% 294 of 1,142
CKD (eGFR<60)8.9% 58 of 652
Hypothyroid25.8% 127 of 492
High LDL10.1% 37 of 366
Anaemia39.9% 143 of 358
High TG22.4% 57 of 254
Transaminitis24.4% 54 of 221
Hyperuricaemia30.5% 57 of 187
One in four people whose sugar or thyroid was normal at first had crossed over by a later test. People who come back are not a random sample: many return because something felt wrong, so these rates are high for the population. Subclinical hypothyroidism mostly settled: 56% normalised and 3.2% became overt (n 570).
The follow-up tool, on demo patients
Real names and phone numbers cannot go on a public page, so this section runs the follow-up tool on a simulated cohort shaped like the lab's records. It shows how condition lists merge into one call per person; none of its counts are findings.
11,403 simulated peopleas of 23 Sep 2026
Calls this week
keep-in-care queues, all five conditions, simulated
One list per condition1,801
One call per person1,397
22.4% fewer calls for the same overdue checks. Each call books one home collection, and every overdue test runs from the same blood draw; only the urine ACR needs a second container.
If someone is on this list, how often are they on that one
% on the row's pathway also on the column's, simulated
Diabetes has its own page, /diabetes. Each tab below holds a condition's simulated cohort, who gets lost, its call list and the guideline rules behind it.
Kidney disease follow-up, from creatinine the lab already runs
Creatinine is one of the most-ordered tests at Anubhav Life Care, Barasat, but the report shows a number in mg/dL, not kidney function. This tab turns every creatinine into an eGFR, confirms chronic kidney disease the way KDIGO asks (a raised marker lasting more than three months), sets the recall interval from the KDIGO heat map, and ranks who to call when the next check is missed.
661
people on the follow-up pathway
of 6,185 tested
40.5%
of them lost to follow-up now
268 people, 180+ days past due
147
overdue, still reachable
0 to 180 days past due
40
critical + high this week
the top of the call list
Where the cohort stands today
Everyone with at least one of the relevant tests (8,329bills), using each person's latest results. Linking turned the 12,343 PATIENT_KEYs across all their visits into 6,185 people.
Who was tested
sex as recorded; age at latest visit
6,185
people
52 : 48
female : male
569
18–29
1,062
30–39
1,648
40–49
1,482
50–59
844
60–69
580
70+
Latest eGFR
5,836 people
G1 ≥ 903,40958%
G2 60–891,82331%
G3a 45–592785%
G3b 30–442064%
G4 15–291002%
G5 < 15200%
On the pathway, by sex and age
% of people tested with egfr under 60 or urine acr 30+
age
18–2930–3940–4950–5960–6970+
Female
2%
4%
7%
11%
18%
28%
Male
2%
4%
10%
12%
15%
24%
A referral lab, not a survey: people are tested because a doctor suspected something. The age gradient is the useful part.
Where people on the pathway sit now
n = 661; 42.1% also have a diabetic-range result
Raised once, not yet confirmed48.1% 318
CKD, very high risk21% 139
CKD, high risk17.4% 115
CKD, moderate risk12.9% 85
CKD, low risk0.6% 4
KDIGO grid for everyone on the pathway
latest eGFR stage × latest urine ACR, n = 641; colour is KDIGO risk, small number is checks per year
eGFR stage
A1 < 30
A2 30–300
A3 > 300
ACR never done
G1 ≥ 90
01×
91×
02×
0
G2 60–89
31×
181×
62×
1
G3a 45–59
521×
482×
53×
173
G3b 30–44
472×
493×
53×
105
G4 15–29
313×
263×
44×
39
G5 < 15
94×
44×
14×
6
324 of 641 people (51%) have never had a urine ACR, so their real KDIGO risk is unknown. Albuminuria is the earlier and cheaper warning; this column is the first thing to fix.
People with diabetes: the yearly kidney pair
n = 2,018 with a diabetic-range result
Ever had a creatinine (eGFR)69.7%
Ever had a urine ACR25.7%
ADA and KDIGO ask for both every year. The blood test is routine; the urine test that catches diabetic kidney disease earliest is the one that gets skipped.
Found only by urine
people on the pathway with a normal eGFR but ACR 30+
51
people
7.7%
of the pathway
Without urine ACR these people would not be on any list: their creatinine looks fine.
Following the same people over time
The clock starts at each person's first result that put them on the pathway. Someone is lost to follow-up once they are more than 180 days past their due date with no follow-up test here.
The follow-up cascade
people who joined the pathway at least 12 months ago, n = 441; each step counts people who also passed every step above
eGFR under 60 or urine ACR 30+100% 441
Came back for any follow-up test67.1% 296
Repeat within 4 months (confirms CKD)15% 66
Still testing in the last 12 months8.8% 39
Both eGFR and urine ACR in the last year4.8% 21
Show as table
Step
People
% of start
eGFR under 60 or urine ACR 30+
441
100%
Came back for any follow-up test
296
67.1%
Repeat within 4 months (confirms CKD)
66
15%
Still testing in the last 12 months
39
8.8%
Both eGFR and urine ACR in the last year
21
4.8%
Still in care, months after the first abnormal result
Kaplan-Meier, censored at 23 Sep 2026
Own mobile on file (n = 524)
Agent's number or none (n = 137)
At 12 months 54% of people with their own number are still in care, against 13% without one (only 10 still at risk in that group by then, so the line stops early).
Gap between consecutive eGFR tests
748 repeat tests in people on the pathway
25%
≤ 3 mo
39%
3–6 mo
17%
6–9 mo
9%
9–12 mo
6%
12–18 mo
5%
> 18 mo
Within 6 months
Longer
36% of repeat tests arrive more than 6 months after the previous one, even among people who do come back.
Month-end status of everyone on the pathway so far
last 24 months
0
400
800
Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26
On track or due soon
Overdue, still reachable (0 to 180 days)
Lost (over 180 days past due)
The lost pool grows from 61 to 268. The overdue-but-reachable band averages 141 over the last six months: that middle band is where a call list pays off.
Show as table
Month end
On track
Overdue
Lost
31 Oct 2024
116
82
61
30 Nov 2024
117
80
73
31 Dec 2024
124
90
76
31 Jan 2025
136
91
80
28 Feb 2025
137
96
95
31 Mar 2025
144
99
99
30 Apr 2025
145
107
107
31 May 2025
150
113
116
30 Jun 2025
151
116
127
31 Jul 2025
163
120
135
31 Aug 2025
169
110
151
30 Sep 2025
168
118
156
31 Oct 2025
184
125
159
30 Nov 2025
189
123
174
31 Dec 2025
198
117
187
31 Jan 2026
194
131
196
28 Feb 2026
202
130
201
31 Mar 2026
221
129
207
30 Apr 2026
229
128
215
31 May 2026
227
141
226
30 Jun 2026
232
148
230
31 Jul 2026
239
132
251
31 Aug 2026
213
152
265
23 Sep 2026
246
147
268
Who gets lost
Share of people lost within 12 months of joining the pathway, among those who joined at least a year ago. Overall: 53.5%. People without their own mobile on file are lost at 89% and 85%, against 46% for people with one.
Contact on file
% lost within 12 months
Own mobile46% n = 359
Agent's number only89% n = 55
No usable number85% n = 27
First came through
% lost within 12 months
Walk-in, Barasat51% n = 223
Home collection52% n = 103
Partner centre62% n = 58
Screening camp58% n = 57
Age
% lost within 12 months
Under 4063% n = 35
40 to 5954% n = 215
60 and over52% n = 191
Also has diabetes
% lost within 12 months
Diabetic-range result on file46% n = 197
No diabetic-range result59% n = 244
This week's eGFR call list
People who can still be kept are ranked by how sick and how late they are; people already lost go to a slower re-engagement queue. 230 to keep in care, 268 to re-engage; the top 120 and 40 are loaded here. Open a name to see the timeline.
Keep-in-care queue by who acts
178Care coordinator
24Collection agent
15Duty doctor
13Referring doctor / outreach
120 match · top 120 of 230 in this queue loaded · 0 actioned · 0 booked
PriorityPatientLast eGFRWhenWhyNext stepStatus
Critical80
P-05827 · F · 65y99xxx xx254
33 mL/min↓9.0eGFR · 7 Jan 2026
Overdue 137 dayslast test 7 Jan 2026
Nephrology referral rangeeGFR falling fast+1
Doctor call first. Book creatinine + urine ACR, refer to nephrologyDuty doctor
Critical79
P-06984 · M · 42y85xxx xx616
19 mL/min↓12eGFR · 18 Dec 2025
Overdue 157 dayslast test 18 Dec 2025
Nephrology referral rangeeGFR falling fast+2
Doctor call first. Book creatinine + urine ACR, refer to nephrologyDuty doctor
Critical77
P-05492 · M · 58y82xxx xx949
25 mL/min↓16eGFR · 23 Jan 2026
Overdue 121 dayslast test 23 Jan 2026
Nephrology referral rangeeGFR falling fast+2
Doctor call first. Book creatinine + urine ACR, refer to nephrologyDuty doctor
Critical72
P-02278 · F · 79y90xxx xx126
33 mL/min↓5.0eGFR · 17 Sep 2025
Overdue 160 dayslast test 15 Dec 2025
eGFR falling fastKidney check overdue
Doctor call first. Book creatinine + urine ACRDuty doctor
Critical70
P-06796 · F · 40y98xxx xx669
11 mL/min↓12eGFR · 20 Mar 2026
Overdue 96 dayslast test 20 Mar 2026
Nephrology referral rangeeGFR falling fast+1
Doctor call first. Book creatinine + urine ACR, refer to nephrologyDuty doctor
High69
P-03454 · F · 55y97xxx xx825
24 mL/mineGFR · 9 Dec 2025
Overdue 166 dayslast test 9 Dec 2025
Nephrology referral rangeUrine ACR never done+1
Book creatinine + urine ACR, refer to nephrologyCare coordinator
High69
P-04732 · M · 45y83xxx xx089
25 mL/mineGFR · 9 Jan 2026
Overdue 135 dayslast test 9 Jan 2026
Nephrology referral rangeUrine ACR never done+1
Book creatinine + urine ACR, refer to nephrologyCare coordinator
High67
P-01014 · M · 49y78xxx xx665
44 mL/mineGFR · 1 Dec 2025
Overdue 174 dayslast test 1 Dec 2025
eGFR falling fastKidney check overdue
Book creatinine + urine ACRCare coordinator
High66
P-07749 · F · 61y99xxx xx046
25 mL/min↓10eGFR · 3 Feb 2026
Overdue 110 dayslast test 3 Feb 2026
Nephrology referral rangeUrine ACR never done+1
Book creatinine + urine ACR, refer to nephrologyCare coordinator
High66
P-04914 · M · 80y92xxx xx331
37 mL/min↓6.0eGFR · 27 Feb 2026
Overdue 86 dayslast test 27 Feb 2026
eGFR falling fastKidney check overdue
Book creatinine + urine ACRCare coordinator
High65
P-03070 · M · 56y81xxx xx601
28 mL/mineGFR · 2 Dec 2025
Overdue 173 dayslast test 2 Dec 2025
Nephrology referral rangeKidney check overdue
Book creatinine + urine ACR, refer to nephrologyCare coordinator
High65
P-07143 · M · 47y94xxx xx166
27 mL/mineGFR · 2 Jan 2026
Overdue 142 dayslast test 2 Jan 2026
Nephrology referral rangeKidney check overdue
Book creatinine + urine ACR, refer to nephrologyCare coordinator
High65
P-07117 · M · 89y78xxx xx158
20 mL/mineGFR · 15 Feb 2026
Overdue 98 dayslast test 15 Feb 2026
Nephrology referral rangeKidney check overdue
Book creatinine + urine ACR, refer to nephrologyCare coordinator
Critical65
P-01343 · M · 65y87xxx xx594
5.0 mL/min↓3.0eGFR · 5 Sep 2026
Due in 73 dayslast test 5 Sep 2026
Very low eGFR or sudden dropNephrology referral range+1
Doctor callback within 48 h, repeat creatinine + electrolytesDuty doctor
Critical64
P-02223 · F · 49y75xxx xx279
8.0 mL/min↓9.0eGFR · 7 Jul 2026
Due in 13 dayslast test 7 Jul 2026
Very low eGFR or sudden dropNephrology referral range+1
Doctor callback within 48 h, repeat creatinine + electrolytesDuty doctor
The rules behind the list
What is due, and when
Trigger
Next step
Basis
First eGFR under 60 or urine ACR 30+
repeat at 90 days
KDIGO: CKD needs more than 3 months of abnormality
Confirmed CKD, KDIGO low or moderate risk
every 365 days
KDIGO heat map: once a year
KDIGO high risk (e.g. G3a A2, G3b A1)
every 183 days
KDIGO heat map: twice a year
KDIGO very high risk (G3b A2+, G4)
every 122 days
KDIGO heat map: three times a year
G4 A3 or G5
every 91 days
KDIGO heat map: four or more times a year
eGFR under 30 or ACR over 300
nephrology referral
KDIGO referral criteria
eGFR falling 5+ mL/min a year
flagged on the list
KDIGO: rapid progression
No kidney test > 180 days past due
marked lost to follow-up
Same rule as the diabetes list
How the priority score is built
0 to 100
Factor
Points
KDIGO risk low / moderate / high / very high
8 / 14 / 24 / 32
Raised once, not yet confirmed
20
In nephrology referral range
+8
eGFR falling 5+ a year
+10
Urine ACR never done
+4
eGFR under 15, or down 30% within 90 days
+10, forces Critical
Days past due (peaks at 180, then decays)
up to 25
Due within the next 30 days
4
Age 65+
5
Critical 70+ (or a result that forces it), High 55 to 69, Medium 38 to 54, Routine below 38.
Definitions and blind spots
eGFR from serum creatinine with the race-free CKD-EPI 2021 equation, using sex and age on the bill; when no sex is recorded (56people) no eGFR is computed rather than guessed. A kidney marker is eGFR under 60 or urine ACR 30 mg/g or more. CKD is confirmed when markers are at least 90 days apart; a single raised marker is “not yet confirmed” and recalled at 3 months. Staging uses the latest eGFR (G1 to G5) and latest ACR (A1 to A3); when ACR was never done the person is staged as A1, which understates risk.
Blood pressure, ACE inhibitor or SGLT2 inhibitor use and dialysis status are not in lab data, and acute illness can lower eGFR for a while.
Cholesterol follow-up, so LDL reaches target and stays there
Heart attack and stroke are the largest cause of death in India, and LDL cholesterol is the risk factor a lab can measure and a cheap tablet can move. This tab links every lipid profile done at Anubhav Life Care, Barasatinto one timeline per person, judges LDL against the target for that person's risk, and ranks who to call when the recheck after a statin change never happens.
1,477
people on the follow-up pathway
of 5,278 tested
48.7%
of them lost to follow-up now
720 people, 180+ days past due
332
overdue, still reachable
0 to 180 days past due
13
critical + high this week
the top of the call list
Where the cohort stands today
Everyone with at least one relevant test (7,787bills), using each person's latest results. Linking turned the 10,832 PATIENT_KEYs across all their visits into 5,278 people.
Who was tested
sex as recorded; age at latest visit
5,278
people
51 : 49
female : male
387
18–29
730
30–39
1,478
40–49
1,384
50–59
770
60–69
529
70+
Latest LDL
5,278 people
< 7051810%
70–991,41827%
100–1291,82635%
130–1591,20223%
160–1892455%
≥ 190691%
On the pathway, by sex and age
% of people tested with ldl 160+, or 100+ with diabetes or ckd, or tg 500+
age
18–2930–3940–4950–5960–6970+
Female
15%
23%
27%
28%
35%
36%
Male
14%
21%
30%
29%
36%
31%
Share with a lipid result that needs action. People with diabetes or kidney disease have a stricter target, so the curve climbs with age as those conditions accumulate.
Where people on the pathway sit now
n = 1,477; 61.3% also have a diabetic-range result
Diabetes or CKD, above LDL 7068.1% 1,006
LDL 160 to 18921.2% 313
LDL 190+ (possible familial)9.7% 143
Triglycerides 500+1% 15
LDL at target, by risk group
people on the pathway, latest LDL
Diabetes or CKD (target < 70)8.5% 90 / 1,059
Everyone else (target < 100)12.9% 54 / 418
The people with the most to gain are the least often at target. The high-risk target is stricter, and a single statin dose rarely gets there without a recheck and a dose change.
Diabetes or CKD, never a lipid profile
n = 2,386 high-risk people
930
never had a lipid profile here
39%
of high-risk people
These people are not on the cholesterol list at all, because nobody ordered the test. The diabetes list carries the reminder.
LDL 190 and over: test the family
possible familial hypercholesterolaemia, relatives found through a shared household mobile
143
people with any LDL 190+
88
household members on the same number
37
of them never had a lipid profile
Familial hypercholesterolaemia passes to half of first-degree relatives and is treatable from childhood. The linking step that separates family members on one phone number is the same step that finds who to test next.
Following the same people over time
The clock starts at each person's first result that put them on the pathway. Someone is lost to follow-up once they are more than 180 days past their due date with no follow-up test here.
The follow-up cascade
people who joined the pathway at least 12 months ago, n = 964; each step counts people who also passed every step above
LDL 160+, or 100+ with diabetes or CKD, or TG 500+100% 964
Came back for any follow-up test64.8% 625
Repeat lipid profile within 4 months31.4% 303
Still testing in the last 12 months15.9% 153
Latest LDL at target3.3% 32
Show as table
Step
People
% of start
LDL 160+, or 100+ with diabetes or CKD, or TG 500+
964
100%
Came back for any follow-up test
625
64.8%
Repeat lipid profile within 4 months
303
31.4%
Still testing in the last 12 months
153
15.9%
Latest LDL at target
32
3.3%
Still in care, months after the first abnormal result
Kaplan-Meier, censored at 23 Sep 2026
Own mobile on file (n = 1,202)
Agent's number or none (n = 275)
At 12 months 53% of people with their own number are still in care, against 23% without one.
Gap between consecutive LDL tests
2,033 repeat tests in people on the pathway
46%
≤ 3 mo
35%
3–6 mo
8%
6–9 mo
4%
9–12 mo
4%
12–18 mo
3%
> 18 mo
Within 6 months
Longer
19% of repeat tests arrive more than 6 months after the previous one, even among people who do come back.
Month-end status of everyone on the pathway so far
last 24 months
0
1,000
2,000
Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26
On track or due soon
Overdue, still reachable (0 to 180 days)
Lost (over 180 days past due)
The lost pool grows from 148 to 720. The overdue-but-reachable band averages 323 over the last six months: that middle band is where a call list pays off.
Show as table
Month end
On track
Overdue
Lost
31 Oct 2024
236
196
148
30 Nov 2024
246
201
169
31 Dec 2024
267
199
189
31 Jan 2025
267
215
207
28 Feb 2025
274
221
228
31 Mar 2025
284
228
250
30 Apr 2025
285
235
267
31 May 2025
289
250
286
30 Jun 2025
296
268
305
31 Jul 2025
307
263
333
31 Aug 2025
302
273
363
30 Sep 2025
315
275
383
31 Oct 2025
355
261
400
30 Nov 2025
356
267
432
31 Dec 2025
357
288
452
31 Jan 2026
356
300
479
28 Feb 2026
374
286
506
31 Mar 2026
367
313
536
30 Apr 2026
389
319
561
31 May 2026
394
320
599
30 Jun 2026
402
304
639
31 Jul 2026
387
333
669
31 Aug 2026
387
332
695
23 Sep 2026
425
332
720
Who gets lost
Share of people lost within 12 months of joining the pathway, among those who joined at least a year ago. Overall: 51.6%. People without their own mobile on file are lost at 76% and 79%, against 47% for people with one.
Contact on file
% lost within 12 months
Own mobile47% n = 803
Agent's number only76% n = 98
No usable number79% n = 63
First came through
% lost within 12 months
Walk-in, Barasat49% n = 516
Home collection52% n = 224
Partner centre56% n = 119
Screening camp55% n = 105
Age
% lost within 12 months
Under 4051% n = 144
40 to 5953% n = 528
60 and over50% n = 292
Also has diabetes
% lost within 12 months
Diabetic-range result on file51% n = 592
No diabetic-range result53% n = 372
This week's LDL call list
People who can still be kept are ranked by how sick and how late they are; people already lost go to a slower re-engagement queue. 423 to keep in care, 720 to re-engage; the top 120 and 40 are loaded here. Open a name to see the timeline.
Keep-in-care queue by who acts
353Care coordinator
45Collection agent
25Referring doctor / outreach
120 match · top 120 of 423 in this queue loaded · 0 actioned · 0 booked
PriorityPatientLast LDLWhenWhyNext stepStatus
High69
P-03517 · F · 54y84xxx xx250
210 mg/dL↑59LDL cholesterol · 27 Feb 2026
Overdue 118 dayslast test 27 Feb 2026
LDL above targetLDL 190+: test the family+2
Book lipid profile (6 to 12 weeks after any statin change), offer family a lipid testCare coordinator
High65
P-09111 · M · 64y92xxx xx043
268 mg/dLLDL cholesterol · 11 Jan 2026
Overdue 165 dayslast test 11 Jan 2026
LDL above targetLDL 190+: test the family+1
Book lipid profile (6 to 12 weeks after any statin change), offer family a lipid testCare coordinator
High65
P-04773 · F · 63yagent's number only
195 mg/dL↑61LDL cholesterol · 7 Feb 2026
Overdue 138 dayslast test 7 Feb 2026
LDL above targetLDL 190+: test the family+2
Book lipid profile (6 to 12 weeks after any statin change), offer family a lipid testPartner centre 3
High64
P-09423 · F · 59y91xxx xx961
200 mg/dLLDL cholesterol · 16 Feb 2026
Overdue 129 dayslast test 16 Feb 2026
LDL above targetLDL 190+: test the family+1
Book lipid profile (6 to 12 weeks after any statin change), offer family a lipid testCare coordinator
High60
P-09141 · M · 70y78xxx xx794
166 mg/dLLDL cholesterol · 14 Jan 2026
Overdue 162 dayslast test 14 Jan 2026
LDL above targetLipid profile overdue
Book lipid profile (6 to 12 weeks after any statin change)Care coordinator
High57
P-06310 · F · 68y77xxx xx930
182 mg/dLLDL cholesterol · 9 Mar 2026
Overdue 108 dayslast test 9 Mar 2026
LDL above targetLipid profile overdue
Book lipid profile (6 to 12 weeks after any statin change)Care coordinator
High57
P-09854 · F · 46yagent's number only
194 mg/dLLDL cholesterol · 12 Apr 2026
Overdue 74 dayslast test 12 Apr 2026
LDL above targetLDL 190+: test the family+1
Book lipid profile (6 to 12 weeks after any statin change), offer family a lipid testHome-collection agent 07
High56
P-04903 · F · 81y91xxx xx042
126 mg/dL↑64LDL cholesterol · 23 Jan 2026
Overdue 153 dayslast test 23 Jan 2026
LDL above targetLDL up 30+ since last+1
Book lipid profile (6 to 12 weeks after any statin change)Care coordinator
High56
P-08403 · M · 58y78xxx xx741
237 mg/dL↓29LDL cholesterol · 19 Apr 2026
Overdue 67 dayslast test 19 Apr 2026
LDL above targetLDL 190+: test the family+1
Book lipid profile (6 to 12 weeks after any statin change), offer family a lipid testCare coordinator
High55
P-00519 · M · 61y76xxx xx744
178 mg/dL↑20LDL cholesterol · 12 Jan 2026
Overdue 164 dayslast test 12 Jan 2026
LDL above targetLDL 190+: test the family+1
Book lipid profile (6 to 12 weeks after any statin change), offer family a lipid testCare coordinator
High55
P-01793 · M · 21y91xxx xx250
177 mg/dL↑57LDL cholesterol · 3 Feb 2026
Overdue 142 dayslast test 3 Feb 2026
LDL above targetLDL up 30+ since last+1
Book lipid profile (6 to 12 weeks after any statin change)Care coordinator
High55
P-01060 · M · 44y71xxx xx108
192 mg/dLLDL cholesterol · 12 Mar 2026
Overdue 105 dayslast test 12 Mar 2026
LDL above targetLDL 190+: test the family+1
Book lipid profile (6 to 12 weeks after any statin change), offer family a lipid testCare coordinator
High55
P-02414 · M · 36y79xxx xx584
224 mg/dLLDL cholesterol · 12 Mar 2026
Overdue 105 dayslast test 12 Mar 2026
LDL above targetLDL 190+: test the family+1
Book lipid profile (6 to 12 weeks after any statin change), offer family a lipid testCare coordinator
Medium54
P-04770 · M · 78yno usable number
130 mg/dLLDL cholesterol · 7 Feb 2026
Overdue 138 dayslast test 7 Feb 2026
LDL above targetLipid profile overdue
Book lipid profile (6 to 12 weeks after any statin change)Dr. J. Das (Medicine)
Medium54
P-09428 · M · 43y94xxx xx853
168 mg/dLLDL cholesterol · 17 Feb 2026
Overdue 128 dayslast test 17 Feb 2026
LDL above targetLipid profile overdue
Book lipid profile (6 to 12 weeks after any statin change)Care coordinator
The rules behind the list
What is due, and when
Trigger
Next step
Basis
LDL at or above target
every 90 days
Recheck 6 to 12 weeks after a statin is started or changed
Critical 70+ (or a result that forces it), High 55 to 69, Medium 38 to 54, Routine below 38.
Definitions and blind spots
High risk means a diabetic-range result (HbA1c 6.5%+ or fasting glucose 126+) or an eGFR under 60 anywhere on the timeline; target LDL under 70 mg/dL. Everyone else: under 100. A person joins the pathway with LDL 160+, LDL 100+ when high risk, or triglycerides 500+. LDL 190+ at any point is flagged as possible familial hypercholesterolaemia. Household members are people sharing the same own mobile number after linking.
Smoking, blood pressure, previous heart attack or stroke and statin prescriptions are not in lab data, so some people placed at moderate risk are really very high risk with a stricter target of 55.
Thyroid follow-up, from the first odd TSH to a stable dose
Hypothyroidism is common in India, mostly in women, and much of it goes undetected. Treatment is a daily tablet, but the dose is only right if TSH is rechecked after every change. This tab links every TSH done at Anubhav Life Care, Barasat into one timeline per person, confirms a single abnormal result before it becomes a lifelong diagnosis, and ranks who to call when the recheck is missed.
630
people on the follow-up pathway
of 4,047 tested
50.2%
of them lost to follow-up now
316 people, 180+ days past due
113
overdue, still reachable
0 to 180 days past due
19
critical + high this week
the top of the call list
Where the cohort stands today
Everyone with at least one relevant test (5,422bills), using each person's latest results. Linking turned the 8,478 PATIENT_KEYs across all their visits into 4,047 people.
Who was tested
sex as recorded; age at latest visit
4,047
people
70 : 30
female : male
420
18–29
717
30–39
1,070
40–49
950
50–59
545
60–69
345
70+
Latest TSH
4,047 people
< 0.1100%
0.1–0.44110%
0.45–4.53,57088%
4.6–102987%
> 101584%
On the pathway, by sex and age
% of people tested with tsh outside 0.45 to 4.5
age
18–2930–3940–4950–5960–6970+
Female
22%
17%
20%
19%
20%
19%
Male
3%
7%
8%
6%
8%
7%
Women dominate at every age. Among people tested here the gap is wide enough to plan outreach around.
Where people on the pathway sit now
n = 630; 22.4% also have a diabetic-range result
Hypothyroid (TSH over 10 at some point)46.7% 294
Abnormal once, repeat pending28.6% 180
Subclinical hypothyroid17% 107
Hyperthyroid (low TSH)7.8% 49
Abnormal TSH, women and men
% of people tested with any TSH outside range
Women19.4% 547 / 2,816
Men6.7% 80 / 1,188
Women are 2.4 times as likely to be tested and 2.9 times as likely to have an abnormal result.
Women 18 to 45 on the pathway
where a missed recheck matters most
236
women 18 to 45
67.4%
overdue or lost now
159 women
Untreated or under-treated hypothyroidism in early pregnancy affects the baby's development. These women are scored up on the list.
Confirm before treating
first TSH 4.6 to 10 with at least one repeat, n = 196
33.7%
came back normal on every repeat
66 people
41.3%
had free T4 with the first abnormal TSH
Mildly raised results often settle on their own. Treating on one result commits people to a lifelong tablet they may not need; the 12-week recall is there to stop that.
Following the same people over time
The clock starts at each person's first result that put them on the pathway. Someone is lost to follow-up once they are more than 180 days past their due date with no follow-up test here.
The follow-up cascade
people who joined the pathway at least 12 months ago, n = 442; each step counts people who also passed every step above
TSH outside 0.45 to 4.5100% 442
Came back for any follow-up test57.5% 254
Repeat TSH within 4 months42.5% 188
Still testing in the last 12 months21.5% 95
Latest TSH back in range12.7% 56
Show as table
Step
People
% of start
TSH outside 0.45 to 4.5
442
100%
Came back for any follow-up test
254
57.5%
Repeat TSH within 4 months
188
42.5%
Still testing in the last 12 months
95
21.5%
Latest TSH back in range
56
12.7%
Still in care, months after the first abnormal result
Kaplan-Meier, censored at 23 Sep 2026
Own mobile on file (n = 498)
Agent's number or none (n = 132)
At 12 months 48% of people with their own number are still in care, against 15% without one (only 13 still at risk in that group by then, so the line stops early).
Gap between consecutive TSH tests
838 repeat tests in people on the pathway
63%
≤ 3 mo
17%
3–6 mo
7%
6–9 mo
4%
9–12 mo
6%
12–18 mo
3%
> 18 mo
Within 6 months
Longer
20% of repeat tests arrive more than 6 months after the previous one, even among people who do come back.
Month-end status of everyone on the pathway so far
last 24 months
0
400
800
Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26
On track or due soon
Overdue, still reachable (0 to 180 days)
Lost (over 180 days past due)
The lost pool grows from 83 to 316. The overdue-but-reachable band averages 107 over the last six months: that middle band is where a call list pays off.
Show as table
Month end
On track
Overdue
Lost
31 Oct 2024
123
65
83
30 Nov 2024
117
80
89
31 Dec 2024
131
75
98
31 Jan 2025
140
73
109
28 Feb 2025
142
73
118
31 Mar 2025
144
74
130
30 Apr 2025
143
88
135
31 May 2025
148
86
148
30 Jun 2025
143
89
159
31 Jul 2025
139
101
163
31 Aug 2025
150
102
172
30 Sep 2025
164
99
182
31 Oct 2025
170
103
195
30 Nov 2025
162
109
203
31 Dec 2025
163
113
211
31 Jan 2026
168
111
219
28 Feb 2026
177
110
228
31 Mar 2026
179
115
234
30 Apr 2026
181
110
255
31 May 2026
189
107
270
30 Jun 2026
197
95
285
31 Jul 2026
188
109
297
31 Aug 2026
191
108
309
23 Sep 2026
201
113
316
Who gets lost
Share of people lost within 12 months of joining the pathway, among those who joined at least a year ago. Overall: 58.4%. People without their own mobile on file are lost at 82% and 90%, against 52% for people with one.
Contact on file
% lost within 12 months
Own mobile52% n = 357
Agent's number only82% n = 56
No usable number90% n = 29
First came through
% lost within 12 months
Walk-in, Barasat54% n = 226
Home collection56% n = 123
Partner centre69% n = 49
Screening camp73% n = 44
Age
% lost within 12 months
Under 4064% n = 132
40 to 5957% n = 209
60 and over54% n = 101
Also has diabetes
% lost within 12 months
Diabetic-range result on file40% n = 90
No diabetic-range result63% n = 352
This week's TSH call list
People who can still be kept are ranked by how sick and how late they are; people already lost go to a slower re-engagement queue. 165 to keep in care, 316 to re-engage; the top 120 and 40 are loaded here. Open a name to see the timeline.
Keep-in-care queue by who acts
132Care coordinator
20Collection agent
13Referring doctor / outreach
120 match · top 120 of 165 in this queue loaded · 0 actioned · 0 booked
PriorityPatientLast TSHWhenWhyNext stepStatus
High63
P-09306 · F · 28y86xxx xx792
62.8 µIU/mLTSH · 3 Feb 2026
Overdue 176 dayslast test 3 Feb 2026
TSH still out of rangeWoman 18 to 45+1
Book TSH (6 to 8 weeks after any dose change), ask about pregnancy plansCare coordinator
High62
P-04435 · F · 32yagent's number only
22.9 µIU/mL↓18TSH · 21 Mar 2026
Overdue 130 dayslast test 21 Mar 2026
TSH still out of rangeWoman 18 to 45+1
Book TSH (6 to 8 weeks after any dose change), ask about pregnancy plansCamp desk 2
High61
P-09546 · F · 21y71xxx xx478
11.6 µIU/mL↑1.46TSH · 2 Apr 2026
Overdue 118 dayslast test 2 Apr 2026
TSH still out of rangeWoman 18 to 45+1
Book TSH (6 to 8 weeks after any dose change), ask about pregnancy plansCare coordinator
High60
P-03621 · F · 91yno usable number
13.7 µIU/mL↓3.62TSH · 5 Mar 2026
Overdue 146 dayslast test 5 Mar 2026
TSH still out of rangeTSH overdue
Book TSH (6 to 8 weeks after any dose change)Dr. M. Hossain (Medicine)
High59
P-09883 · F · 39y74xxx xx272
13.1 µIU/mLTSH · 14 Apr 2026
Overdue 106 dayslast test 14 Apr 2026
TSH still out of rangeWoman 18 to 45+1
Book TSH (6 to 8 weeks after any dose change), ask about pregnancy plansCare coordinator
High59
P-00384 · F · 44y95xxx xx257
14.8 µIU/mL↑6.03TSH · 19 Apr 2026
Overdue 101 dayslast test 19 Apr 2026
TSH still out of rangeWoman 18 to 45+1
Book TSH (6 to 8 weeks after any dose change), ask about pregnancy plansCare coordinator
High59
P-09915 · F · 20y73xxx xx216
10.4 µIU/mLTSH · 19 Apr 2026
Overdue 101 dayslast test 19 Apr 2026
TSH still out of rangeWoman 18 to 45+1
Book TSH (6 to 8 weeks after any dose change), ask about pregnancy plansCare coordinator
High58
P-09942 · F · 31y93xxx xx715
23.7 µIU/mLTSH · 21 Apr 2026
Overdue 99 dayslast test 21 Apr 2026
TSH still out of rangeWoman 18 to 45+1
Book TSH (6 to 8 weeks after any dose change), ask about pregnancy plansCare coordinator
High58
P-09993 · F · 42yno usable number
10 µIU/mLTSH · 27 Apr 2026
Overdue 93 dayslast test 27 Apr 2026
TSH still out of rangeWoman 18 to 45+1
Book TSH (6 to 8 weeks after any dose change), ask about pregnancy plansDr. N. Sarkar (Gynaecology)
High56
P-10118 · F · 30y99xxx xx206
23.2 µIU/mLTSH · 14 May 2026
Overdue 76 dayslast test 14 May 2026
TSH still out of rangeWoman 18 to 45+1
Book TSH (6 to 8 weeks after any dose change), ask about pregnancy plansCare coordinator
High56
P-10120 · F · 36y71xxx xx036
22 µIU/mLTSH · 14 May 2026
Overdue 76 dayslast test 14 May 2026
TSH still out of rangeWoman 18 to 45+1
Book TSH (6 to 8 weeks after any dose change), ask about pregnancy plansCare coordinator
High55
P-07749 · F · 61y99xxx xx046
18.6 µIU/mLTSH · 3 Feb 2026
Overdue 176 dayslast test 3 Feb 2026
TSH still out of rangeTSH overdue
Book TSH (6 to 8 weeks after any dose change)Care coordinator
High55
P-09371 · F · 60yno usable number
57.8 µIU/mLTSH · 10 Feb 2026
Overdue 169 dayslast test 10 Feb 2026
TSH still out of rangeTSH overdue
Book TSH (6 to 8 weeks after any dose change)Dr. M. Hossain (Medicine)
High55
P-00365 · F · 25y86xxx xx372
0.06 µIU/mL↓1.39TSH · 13 Feb 2026
Overdue 166 dayslast test 13 Feb 2026
TSH still out of rangeTSH overdue
Book TSH (6 to 8 weeks after any dose change)Care coordinator
High55
P-03618 · M · 61y72xxx xx266
27.8 µIU/mLTSH · 15 Feb 2026
Overdue 164 dayslast test 15 Feb 2026
TSH still out of rangeTSH overdue
Book TSH (6 to 8 weeks after any dose change)Care coordinator
The rules behind the list
What is due, and when
Trigger
Next step
Basis
First TSH outside 0.45 to 4.5, under 10 and over 0.1
repeat at 84 days
Subclinical results often settle; confirm first
TSH over 10, under 0.1, or abnormal twice
diagnosis established
ATA / ETA thresholds
Established, TSH out of range
every 56 days
Recheck 6 to 8 weeks after a dose change
Subclinical hypothyroid, still raised
every 180 days
ETA: 6-monthly while untreated
Established, TSH in range
every 365 days
At least yearly once stable
Woman 18 to 45 with TSH over 2.5
pregnancy plans asked
Untreated hypothyroidism harms pregnancy
No TSH > 180 days past due
marked lost to follow-up
Same rule as the diabetes list
How the priority score is built
0 to 100
Factor
Points
Unconfirmed abnormal TSH
18
Established, latest TSH over 10 or under 0.1 / mildly out / in range
30 / 16 / 6
Woman 18 to 45, TSH over 2.5
+8
TSH 50+, or under 0.01 with high free T4
+10, forces Critical
Days past due (peaks at 180, then decays)
up to 25
Due within the next 30 days
4
Age 65+
5
Critical 70+ (or a result that forces it), High 55 to 69, Medium 38 to 54, Routine below 38.
Definitions and blind spots
Reference range 0.45 to 4.5 µIU/mL. Established: any TSH over 10 or under 0.1, or two abnormal results at least 42 days apart. A single subclinical result is “abnormal once” and recalled at 12 weeks; if the repeat is normal the person leaves the pathway. The direction of the first abnormal result sets hypo- versus hyperthyroid. Women 18 to 45 with TSH over 2.5 are flagged because guidance for pregnancy uses that lower threshold.
Whether someone is pregnant or taking thyroxine is not in lab data, so the list cannot tell an untreated person from one on the wrong dose; the reminder asks.
Fatty liver follow-up, scored from tests already on the bill
Fatty liver is common in India and silent until scarring is advanced. The tests that flag who needs a closer look (AST, ALT and a platelet count) are among the most-ordered at Anubhav Life Care, Barasat, yet the report never combines them. This tab computes FIB-4 on every bill where it can be computed, applies the AASLD 2023 cut-offs, and ranks who to call for elastography, referral or a repeat test.
1,376
people on the follow-up pathway
of 4,339 tested
38.4%
of them lost to follow-up now
529 people, 180+ days past due
273
overdue, still reachable
0 to 180 days past due
19
critical + high this week
the top of the call list
Where the cohort stands today
Everyone with at least one relevant test (6,393bills), using each person's latest results. Linking turned the 9,406 PATIENT_KEYs across all their visits into 4,339 people.
Who was tested
sex as recorded; age at latest visit
4,339
people
52 : 48
female : male
382
18–29
713
30–39
1,147
40–49
1,084
50–59
603
60–69
410
70+
Latest FIB-4
4,339 people
Low (< 1.3)2,00846%
Indeterminate (1.3–2.66)3428%
High (≥ 2.67)1614%
Not computable1,82842%
On the pathway, by sex and age
% of people tested with alt over 40 or fib-4 at or above the low cut-off
age
18–2930–3940–4950–5960–6970+
Female
20%
29%
33%
34%
38%
34%
Male
24%
29%
30%
34%
40%
34%
Share with a raised ALT or a FIB-4 above the low cut-off. Raised ALT dominates in the young, FIB-4 in the old.
Where people on the pathway sit now
n = 1,376; 41.7% also have a diabetic-range result
ALT raised, FIB-4 not computable30.4% 418
ALT raised, FIB-4 low27.8% 383
FIB-4 indeterminate24.9% 342
FIB-4 high: likely advanced scarring11.7% 161
Diabetes, FIB-4 now low5.2% 72
FIB-4 the report never printed
bills where AST, ALT and platelets were all present, age 35+
3,368
FIB-4 scores computed here
418
people with raised ALT but no platelets that day
Every one of these scores was computable from tests already paid for. The second number is the cheapest fix: order the blood count with the liver test and the score comes free.
People with diabetes, 35 and over
n = 1,913; AASLD and ADA ask for FIB-4 in everyone with type 2 diabetes
56.2%
ever had a liver test
43.1%
ever had a computable FIB-4
Low58271%
Indeterminate16620%
High769%
29.4% of people with diabetes who were scored need elastography or a referral.
Following the same people over time
The clock starts at each person's first result that put them on the pathway. Someone is lost to follow-up once they are more than 180 days past their due date with no follow-up test here.
The follow-up cascade
people who joined the pathway at least 12 months ago, n = 902; each step counts people who also passed every step above
ALT over 40 or FIB-4 at or above the low cut-off100% 902
Came back for any follow-up test62.7% 566
Repeat LFT within 6 months30.2% 272
Still testing in the last 12 months17% 153
FIB-4 scored in the last 2 years14.1% 127
Show as table
Step
People
% of start
ALT over 40 or FIB-4 at or above the low cut-off
902
100%
Came back for any follow-up test
566
62.7%
Repeat LFT within 6 months
272
30.2%
Still testing in the last 12 months
153
17%
FIB-4 scored in the last 2 years
127
14.1%
Still in care, months after the first abnormal result
Kaplan-Meier, censored at 23 Sep 2026
Own mobile on file (n = 1,105)
Agent's number or none (n = 271)
At 12 months 64% of people with their own number are still in care, against 31% without one.
Gap between consecutive FIB-4 tests
655 repeat tests in people on the pathway
24%
≤ 3 mo
31%
3–6 mo
19%
6–9 mo
11%
9–12 mo
8%
12–18 mo
7%
> 18 mo
Within 6 months
Longer
45% of repeat tests arrive more than 6 months after the previous one, even among people who do come back.
Month-end status of everyone on the pathway so far
last 24 months
0
1,000
2,000
Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26
On track or due soon
Overdue, still reachable (0 to 180 days)
Lost (over 180 days past due)
The lost pool grows from 112 to 529. The overdue-but-reachable band averages 265 over the last six months: that middle band is where a call list pays off.
Show as table
Month end
On track
Overdue
Lost
31 Oct 2024
320
135
112
30 Nov 2024
317
150
121
31 Dec 2024
326
156
136
31 Jan 2025
328
158
156
28 Feb 2025
355
157
163
31 Mar 2025
368
169
173
30 Apr 2025
373
179
189
31 May 2025
384
175
208
30 Jun 2025
387
189
221
31 Jul 2025
388
194
242
31 Aug 2025
422
203
249
30 Sep 2025
439
202
268
31 Oct 2025
451
208
290
30 Nov 2025
451
225
306
31 Dec 2025
487
210
330
31 Jan 2026
506
205
351
28 Feb 2026
506
222
364
31 Mar 2026
522
226
386
30 Apr 2026
536
229
415
31 May 2026
542
239
440
30 Jun 2026
527
277
451
31 Jul 2026
529
290
470
31 Aug 2026
528
279
513
23 Sep 2026
574
273
529
Who gets lost
Share of people lost within 12 months of joining the pathway, among those who joined at least a year ago. Overall: 41.8%. People without their own mobile on file are lost at 70% and 69%, against 36% for people with one.
Contact on file
% lost within 12 months
Own mobile36% n = 742
Agent's number only70% n = 112
No usable number69% n = 48
First came through
% lost within 12 months
Walk-in, Barasat39% n = 469
Home collection37% n = 197
Partner centre55% n = 112
Screening camp51% n = 124
Age
% lost within 12 months
Under 4062% n = 190
40 to 5939% n = 455
60 and over32% n = 257
Also has diabetes
% lost within 12 months
Diabetic-range result on file32% n = 395
No diabetic-range result50% n = 507
This week's FIB-4 call list
People who can still be kept are ranked by how sick and how late they are; people already lost go to a slower re-engagement queue. 320 to keep in care, 529 to re-engage; the top 120 and 40 are loaded here. Open a name to see the timeline.
Keep-in-care queue by who acts
259Care coordinator
40Collection agent
21Referring doctor / outreach
120 match · top 120 of 320 in this queue loaded · 0 actioned · 0 booked
PriorityPatientLast FIB-4WhenWhyNext stepStatus
High68
P-00463 · F · 73y88xxx xx516
4.29 ↑0.72FIB-4 · 20 Feb 2025
Overdue 176 dayslast test 2 Oct 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High68
P-06143 · M · 70yagent's number only
6.71 ↓2.56FIB-4 · 2 Oct 2025
Overdue 176 dayslast test 2 Oct 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCHome-collection agent 03
High68
P-07453 · F · 66y86xxx xx818
2.83 ↑0.36FIB-4 · 6 Oct 2025
Overdue 172 dayslast test 6 Oct 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High68
P-08416 · F · 71y78xxx xx870
6.94 FIB-4 · 21 Oct 2025
Overdue 157 dayslast test 21 Oct 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High67
P-02734 · F · 66y97xxx xx089
2.87 ↓0.95FIB-4 · 16 Nov 2025
Overdue 131 dayslast test 16 Nov 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High63
P-05748 · M · 49y95xxx xx359
3.1 FIB-4 · 15 Oct 2025
Overdue 163 dayslast test 15 Oct 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High63
P-06215 · F · 52y74xxx xx473
2.9 ↓1.04FIB-4 · 9 Nov 2025
Overdue 138 dayslast test 9 Nov 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High63
P-04122 · F · 81y89xxx xx505
2.74 ↑0.46FIB-4 · 23 Dec 2025
Overdue 94 dayslast test 23 Dec 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High62
P-04519 · M · 79y68xxx xx997
5.23 ↑1.85FIB-4 · 7 Oct 2025
Overdue 171 dayslast test 7 Oct 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High62
P-02378 · F · 75y66xxx xx990
6.14 FIB-4 · 4 Nov 2025
Overdue 143 dayslast test 4 Nov 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High62
P-06723 · M · 40y89xxx xx639
3.15 FIB-4 · 22 Nov 2025
Overdue 125 dayslast test 22 Nov 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High60
P-03563 · M · 50y76xxx xx594
2.95 FIB-4 · 6 Dec 2025
Overdue 111 dayslast test 6 Dec 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High59
P-08826 · F · 91yagent's number only
4.76 FIB-4 · 6 Dec 2025
Overdue 111 dayslast test 6 Dec 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCamp desk 3
High58
P-05990 · F · 74y80xxx xx513
3.23 FIB-4 · 15 Dec 2025
Overdue 102 dayslast test 15 Dec 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
High57
P-08248 · M · 38y80xxx xx853
2.94 FIB-4 · 4 Oct 2025
Overdue 174 dayslast test 4 Oct 2025
Refer to liver specialistLiver check overdue
Refer to hepatology, book LFT + CBCCare coordinator
The rules behind the list
What is due, and when
Trigger
Next step
Basis
AST, ALT and platelets on the same bill, age 35+
FIB-4 computed
Lab report does not print it
FIB-4 2.67 or more
hepatology referral, LFT every 180 days
AASLD 2023: high risk of advanced fibrosis
FIB-4 1.3 to 2.66 (2.0 to 2.66 at 65+)
elastography, recheck yearly
AASLD 2023: indeterminate
ALT over 40, no platelets that day
LFT + CBC within 90 days
So FIB-4 can be scored
ALT over 40, FIB-4 low
every 180 days
Persistent raised ALT needs review
Diabetes, FIB-4 low
every 730 days
AASLD / ADA: rescreen every 1 to 2 years
No LFT > 180 days past due
marked lost to follow-up
Same rule as the diabetes list
How the priority score is built
0 to 100
Factor
Points
FIB-4 high / indeterminate / not computable / ALT raised, FIB-4 low / low
32 / 20 / 14 / 12 / 4
Diabetes on file
+6
ALT 200 or more with no repeat
+10, forces Critical
Days past due (peaks at 180, then decays)
up to 25
Due within the next 30 days
4
Age 65+
5
Critical 70+ (or a result that forces it), High 55 to 69, Medium 38 to 54, Routine below 38.
Definitions and blind spots
FIB-4 = age × AST ÷ (platelets × √ALT), computed when all three are on the same bill and the person is 35 or older. Low risk under 1.3 (under 2.0 from age 65), indeterminate up to 2.66, high 2.67 or more. ALT over 40 U/L counts as raised. A person joins the pathway with a raised ALT or a FIB-4 at or above the low cut-off; people with diabetes stay on a two-yearly recall even once low risk, everyone else leaves when both values are back to normal.
Alcohol use, viral hepatitis, ultrasound and elastography results are not in lab data, so FIB-4 here is a risk score for who to send on, not a diagnosis of fatty liver.
How the numbers were made
Real, from the lab:every figure from the top of the page through “What changes in the same person”. A read-only script on the clinic PC pulled structured results, bills and imaging report headers from AKTIV after clinic hours (1,74,520 visits, Oct 2022 to Oct 2026). Visits were linked into people by phone number, name, sex and age with the resolver from the diabetes page. Ultrasound and echo reports were turned into yes/no findings by rule-based extractors that ran on the same PC. Names, phone numbers and report text never left it; this page reads only counts and percentages from etl-ncd/analysis/results.
Real, published: every West Bengal and India figure, each linked to its source.
Simulated: the follow-up tool section and its condition tabs. They run the same rules on a generated cohort, because a working call list needs names and phone numbers.
Limits. These are people a doctor sent for testing, not a sample of West Bengal, so rates run above survey rates wherever testing is selective. Someone with one test here may test elsewhere. The ultrasound findings come from keyword rules that have not yet been checked against a hand-read sample. Linking by name and phone can merge two people or split one. Blood pressure, weight and prescriptions are not in lab records.